These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 8864158

  • 1. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
    Nemeroff CB.
    J Clin Psychiatry; 1989 May; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
    [Abstract] [Full Text] [Related]

  • 3. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF, Bao AM, Lucassen PJ.
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [Abstract] [Full Text] [Related]

  • 4. [The relation between results of thyrotropin-releasing hormone stimulation tests (TRH-ST), dexamethasone suppression test (DST) and urinary MHPG. SO4 excretion in depressive patients].
    Chen G.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Aug; 24(4):203-6, 251. PubMed ID: 1954790
    [Abstract] [Full Text] [Related]

  • 5. Endocrine dysfunction in anorexia nervosa and bulimia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors.
    Hudson JI, Hudson MS.
    Psychiatr Dev; 1984 Aug; 2(4):237-72. PubMed ID: 6098898
    [Abstract] [Full Text] [Related]

  • 6. Alterations in hypothalamic-pituitary-adrenal/thyroid (HPA/HPT) axes correlated with the clinical manifestations of depression.
    Min W, Liu C, Yang Y, Sun X, Zhang B, Xu L, Sun X.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct 01; 39(1):206-11. PubMed ID: 22750689
    [Abstract] [Full Text] [Related]

  • 7. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J, Ishitobi Y, Ninomiya T, Kanehisa M, Imanaga J, Inoue A, Okamoto S, Maruyama Y, Higuma H, Tanaka Y, Hanada H, Isogawa K, Akiyoshi J.
    Neuro Endocrinol Lett; 2013 Oct 01; 34(5):409-17. PubMed ID: 23922049
    [Abstract] [Full Text] [Related]

  • 8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A.
    Nervenarzt; 2003 Mar 01; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [Abstract] [Full Text] [Related]

  • 9. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K, Rybakowski J.
    Psychiatr Pol; 1996 Mar 01; 30(5):741-55. PubMed ID: 8984515
    [Abstract] [Full Text] [Related]

  • 10. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 01; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 11. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A, Taneli B, Sivrioğlu Y.
    Turk Psikiyatri Derg; 2003 Mar 01; 14(2):116-24. PubMed ID: 12844278
    [Abstract] [Full Text] [Related]

  • 12. Hypercortisolemia and depression.
    Gillespie CF, Nemeroff CB.
    Psychosom Med; 2005 Mar 01; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [Abstract] [Full Text] [Related]

  • 13. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 01; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 14. Hypofunction of the stress axis in Sjögren's syndrome.
    Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 1998 Aug 01; 25(8):1508-14. PubMed ID: 9712092
    [Abstract] [Full Text] [Related]

  • 15. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987 Aug 01; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 16. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct 01; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 18. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR, Nemeroff CB.
    J Clin Psychiatry; 1993 Jan 01; 54 Suppl():16-9. PubMed ID: 8093884
    [Abstract] [Full Text] [Related]

  • 19. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G.
    J Affect Disord; 2007 Jun 01; 100(1-3):65-73. PubMed ID: 17098292
    [Abstract] [Full Text] [Related]

  • 20. [Hypophyseal-hypothalamo-thyroid axis in affective disorders].
    Hofmann P, Schrötter KH.
    Acta Med Austriaca; 1999 Jun 01; 26(4):123-5. PubMed ID: 10526629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.